Table 1.
Monitoring in diabetes and considerations for precision monitoring
| Monitoring method | Monitored variable | Mode of monitoring | Considerations for precision monitoring |
|---|---|---|---|
| Laboratory analysis |
HbA1c Glucose Lipids Markers of inflammation Genetic information |
Active | Monitoring of risk-factors for complications |
| Self-monitored blood glucose |
Current glucose level Distribution of glucose values |
Active |
Dose adaptation Definition of risk groups for acute complications Frequency of required measurements is uncertain |
| Blinded CGM |
Retrospective daily glucose control Distribution of glucose values |
Passive |
Definition of risk groups for acute complications Glucose patterns Meeting of treatment targets No reactive measurement of glycaemic control Possibility of intermittent use is uncertain |
| Real-time CGM |
Past glucose course Current glucose level Trend in glucose level Distribution of glucose values |
Passive/active |
Definition of risk groups for acute complications Glucose patterns Meeting of treatment targets Possibility of intermittent use is uncertain |
| EMA |
Mental health (patient-reported outcomes): Stress Mood/Affect Diabetes distress Quality of life Depressive symptoms Diabetes symptoms Fear of hypoglycaemia |
Active |
Identification of impaired mental health Automated analysis resulting in meaningful variables needed Automated integration with glucose data needed Timing and duration of prompts is uncertain Number of daily prompts is uncertain Use of validated questions from established questionnaires is uncertain |
|
Self-care behaviour (self-report), eating: Meal size Timing Food choices Portion size Context of eating (e.g. stress eating, boredom) Disordered eating |
Active |
Effect of lifestyle interventions Motivation for lifestyle interventions Visibility of the effects of different foods on glucose Potential bias by socially desirable responses |
|
|
Self-care behaviour (self-report), treatment adherence: Timing of medication (e.g. insulin) No. of medications taken/injections Dosage of medication |
Active |
Effect of monitoring on adherence Potential bias by socially desirable responses |
|
|
Self-care behaviour (self-report), sleep: Sleep-in and wake-up time Sleep quality |
Active |
Impact of sleep quality on glucose metabolism (vice versa) Mental health and sleep Potential bias by socially desirable responses |
|
| Wearable sensor-wristbands |
Physical activity: Steps Distance covered Heart rate Intensity Oxygen saturation |
Passive |
Effect of lifestyle interventions Motivation for lifestyle interventions Visibility of the effects of physical activity on glucose Correspondence to self-report Validity of data is difficult to ascertain Additional device(s) to wear |
|
Sleep: Sleeping hours Time in non-REM/REM Number of awakenings Breathing |
Passive |
Identification of sleep problems Objective variables in addition to perceived sleep quality Validity of data is difficult to ascertain Additional device(s) to wear |
|
|
Physiological arousal: Heart rate Heart rate variability Heart rhythm |
Passive |
Objective variables of stress responsiveness Validity of data is difficult to ascertain Additional device(s) to wear |
|
| Smart pens, pump data storage, electronic medication caps |
Treatment adherence: Timing of medication (e.g. insulin) No. of medications taken/injections Dosage of medication |
Passive |
Detailed analysis of diabetes management Correspondence to self-report Costs Availability |